Highly Sensitized Prospective Kidney Transplant Recipients
2 clinical trials · Condition
◉ Watch Highly Sensitized Prospective Kidney Transplant Recipients
| Record | Firm | Date |
|---|---|---|
| Carfilzomib and Belatacept for Desensitization (NCT05017545) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-12-28 |
| Daratumumab and Belatacept for Desensitization (NCT04827979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-01 |
Track Highly Sensitized Prospective Kidney Transplant Recipients automatically
Every clearance here is in the API, with alerts when new ones post.